Epizyme - Ownership and Business Overview

Life ScienceCompany

Epizyme Ownership

Who owns Epizyme?

Epizyme is owned by Ipsen SA. It was acquired on June 27, 2022.

Was Epizyme formerly PE-backed?

Yes. Epizyme was formerly owned by 1 private investor.

Epizyme Business Overview

Where is Epizyme headquartered?

Epizyme is headquartered in Cambridge, Massachusetts.

What is Epizyme’s revenue?

Epizyme disclosed revenue of 37M USD for 2021 and 16M USD for 2020.

How many employees does Epizyme have?

Epizyme has 250 employees.

What sector is Epizyme in?

Epizyme is a life science company.

When was Epizyme founded?

Epizyme was founded in 2007.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 296 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 259 by strategics.

Epizyme

Epizyme, Inc.

400 Technology Square 4th Floor,
Cambridge, Massachusetts 02139
United States,
(617) 229-5872
www.epizyme.com

Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme was founded in 2007 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.